[1]
Gaber Arean, A. et al. 2025. Exploring the Synergistic Anticancer Potential of Linagliptin and Esomeprazole in Cervical Cancer Cell Line: Mechanistic Insights into Targeting HSPB1, Hsp60. Asian Pacific Journal of Cancer Biology. 10, 3 (Aug. 2025), 645–657. DOI:https://doi.org/10.31557/apjcb.2025.10.3.645-657.